Are We Missing the mTOR Target in Breast Cancer?

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1207-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

New Targets for Therapy in Breast Cancer: Mammalian Target of Rapamycin (mTOR) Antagonists

Breast Cancer Research
Cancer ResearchOncology
2004English

P182 Are We Missing Anorectal Malformations?

2019English

Improving Outcomes in Breast Cancer: Where Should We Target Our Efforts?

Expert Review of Pharmacoeconomics and Outcomes Research
MedicineHealth PolicyPharmacology
2014English

Breast Cancer Research: Where We Are and Where We Should Go

Breast Cancer Research
Cancer ResearchOncology
2000English

Breastfeeding-Associated Hypernatremia: Are We Missing the Diagnosis?

Pediatrics
Child HealthPediatricsPerinatology
2005English

The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

Frontiers in Pharmacology
Pharmacology
2019English

Axillary Surgery in Breast Cancer: Are We Near the End of the Road

Mastology
2019English

The Diversity of Coral Reefs: What Are We Missing?

PLoS ONE
Multidisciplinary
2011English

Treatment for Anorexia Nervosa: Are We Missing the Mark?

Current Research in Psychology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy